drugset / Trial / NCT06699121
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.
Timeline
- Start
- 2025-11
- Primary completion
- 2028-03
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LB-P8 | Unknown | 1e+10 unknown | Oral |
| Subject | LB-P8 | Unknown | 1e+11 unknown | Oral |